[1]
|
Sharma, T., Datta, K.K., Kumar, M., et al. (2020) Intracranial Aneurysm Biomarker Candidates Identified by a Prote-ome-Wide Study. OMICS, 24, 483-492. https://doi.org/10.1089/omi.2020.0057
|
[2]
|
Batista, S., Bocanegra-Becerra, J.E., Claassen, B., et al. (2023) Biomarkers in Aneurysmal Subarachnoid Hemorrhage: A Short Review. World Neurosurgery: X, 19, Article ID: 100205. https://doi.org/10.1016/j.wnsx.2023.100205
|
[3]
|
Lawton, M.T. and Vates, G.E. (217) Subarachnoid Hemorrhage. The New England Journal of Medicine, 377, 257-266.
https://doi.org/10.1056/NEJMcp1605827
|
[4]
|
Maruhashi, T. and Higashi, Y. (2021) An Overview of Pharma-cotherapy for Cerebral Vasospasm and Delayed Cerebral Ischemia after Subarachnoid Hemorrhage. Expert Opinion on Pharmacotherapy, 22, 1601-1614.
https://doi.org/10.1080/14656566.2021.1912013
|
[5]
|
Zhang, Y., Li, L., Jia, L., et al. (2021) Neutrophil Counts as Promising Marker for Predicting in-Hospital Mortality in Aneurysmal Subarachnoid Hemorrhage. Stork, 52, 3266-3275. https://doi.org/10.1161/STROKEAHA.120.034024
|
[6]
|
Bodaghi, A., Fattahi, N. and Ramazani, A. (2023) Biomarkers: Promising and Valuable Tools towards Diagnosis, Prognosis and Treatment of Covid-19 and Other Diseases. Heliyon, 9, E13323.
https://doi.org/10.1016/j.heliyon.2023.e13323
|
[7]
|
Zhang, B., Lin, L., Yuan, F., et al. (2021) Clinical Application Values of Neutrophil-to-Lymphocyte Ratio in Intracranial Aneurysms. Aging, 13, 5250-5262. https://doi.org/10.18632/aging.202445
|
[8]
|
Lucke-Wold, B.P., Logsdon, A.F., Manoranjan, B., et al. (2016) An-eurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive Review. International Journal of Molecular Sciences, 17, Article 497.
https://doi.org/10.3390/ijms17040497
|
[9]
|
Okada, T. and Suzuki, H. (2017) Toll-Like Receptor 4 as a Possible Therapeutic Target for Delayed Brain Injuries after Aneurysmal Subarachnoid Hemorrhage. Neural Regeneration Re-search, 12, 193-196.
https://doi.org/10.4103/1673-5374.200795
|
[10]
|
Vincent, J.L., Donadello, K. and Schmit, X. (2011) Biomarkers in the Critically Ill Patient: C-Reactive Protein. Critical Care Clinics, 27, 241-251. https://doi.org/10.1016/j.ccc.2010.12.010
|
[11]
|
Fountas, K.N., Tasiou, A., Kapsalaki, E.Z., et al. (2009) Serum and Cerebrospinal Fluid C-Reactive Protein Levels as Predictors of Vasospasm in Aneurysmal Subarachnoid Hemorrhage. Neurosurgical Focus, 26, E22.
https://doi.org/10.3171/2009.2.FOCUS08311
|
[12]
|
Alessandro, O., Rene, W., Stefan, W., et al. (2022) C-Reactive Protein Elevation Predicts In-Hospital Deterioration after Aneurysmal Subarachnoid Hemorrhage: A Retrospective Observational Study. Acta Neurochirurgica, 164, 1805- 1814. https://doi.org/10.1007/s00701-022-05256-0
|
[13]
|
Lee, S., Kim, Y.O. and Ryu, J.A. (2020) Clinical Usefulness of Early Serial Measurements of C-Reactive Protein as Outcome Predictors in Patients with Subarachnoid Hemorrhage. BMC Neurology, 20, Article No. 112.
https://doi.org/10.1186/s12883-020-01687-3
|
[14]
|
Gouvê, A., Bogossian, E., Taleb, C., Aspide, R., et al. (2023) Cerebro-Spinal Fluid Glucose and Lactate Concentrations Changes in Response to Therapies in Patients with Primary Brain Injury: The START-TRIP Study. Critical Care, 27, Article No. 130. https://doi.org/10.1186/s13054-023-04409-6
|
[15]
|
Taccone, F.S., Badenes, R., Arib, S., et al. (2020) Cerebrospinal Fluid Glucose and Lactate Levels after Subarachnoid Hemorrhage: A Multicenter Retrospective Study. Journal of Neurosurgical Anesthesiology, 32, 170-176.
https://doi.org/10.1097/ANA.0000000000000584
|
[16]
|
Aisiku, I.P., Chen, P.R., Truong, H., et al. (2016) Admis-sion Serum Lactate Predicts Mortality in Aneurysmal Subarachnoid Hemorrhage. The American Journal of Emergency Medicine, 34, 708-712.
https://doi.org/10.1016/j.ajem.2015.12.079
|
[17]
|
Liu, X., Shen, Y., Wang, H., et al. (2016) Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study. Mediators of In-flammation, 2016, Article ID: 8191254.
https://doi.org/10.1155/2016/8191254
|
[18]
|
Giede-Jeppe, A., Reichl, J., Sprügel, M.I., et al. (2019) Neutro-phil-to-Lymphocyte Ratio as an Independent Predictor for Unfavorable Functional Outcome in Aneurysmal Subarachnoid Hemorrhage. Journal of Neurosurgery, 132, 400- 407. https://doi.org/10.3171/2018.9.JNS181975
|
[19]
|
Shi, M., Yang, C., Tang, Q.W., et al. (2021) The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Observational Studies. Frontiers in Neurology, 12, Article 745560. https://doi.org/10.3389/fneur.2021.745560
|
[20]
|
Lucke-Wold, B., Hosaka, K., Dodd, W., et al. (2021) Interleukin-6: Important Mediator of Vasospasm Following Subarachnoid Hemorrhage. Current Neurovascular Research, 18, 364-369.
https://doi.org/10.2174/1567202618666211104122408
|
[21]
|
Kao, H.W., Lee, K.W., Kuo, C.L., et al. (2015) In-terleukin-6 as a Prognostic Biomarker in Ruptured Intracranial Aneurysms. PLOS ONE, 10, e132115. https://doi.org/10.1371/journal.pone.0132115
|
[22]
|
Chaudhry, S.R., Stoffel-Wagner, B., Kinfe, T.M., et al. (2017) Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications. International Journal of Molecular Sciences, 18, Article 2580. https://doi.org/10.3390/ijms18122580
|
[23]
|
Wang, W.X., Springer, J.E. and Hatton, K.W. (2021) MicroRNAs as Biomarkers for Predicting Complications Following Aneurysmal Subarachnoid Hemorrhage. International Journal of Molecular Sciences, 22, Article 9492.
https://doi.org/10.3390/ijms22179492
|
[24]
|
Müller, A.H., Povlsen, G.K., Bang-Berthelsen, C.H., et al. (2015) Regulation of MicroRNAs MiR-30a and MiR-143 in Cerebral Vasculature after Experimental Subarachnoid Hemorrhage in Rats. BMC Genomics, 16, Article No. 119.
https://doi.org/10.1186/s12864-015-1341-7
|
[25]
|
Liu, D., Han, L., Wu, X., et al. (2014) Genome-Wide MicroRNA Changes in Human Intracranial Aneurysms. BMC Neurology, 14, Article No. 188. https://doi.org/10.1186/s12883-014-0188-x
|
[26]
|
Supriya, M., Christopher, R., Indira Devi, B., et al. (2020) Cir-culating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture. Molecular Diagnosis & Therapy, 24, 351-364.
https://doi.org/10.1007/s40291-020-00465-8
|
[27]
|
Lai, N.S., Zhang, J.Q., Qin, F.Y., et al. (2017) Serum MicroRNAs Are Non-Invasive Biomarkers for the Presence and Progression of Subarachnoid Haemorrhage. Bioscience Reports, 37, BSR20160480.
https://doi.org/10.1042/BSR20160480
|
[28]
|
Hong, C.M., Tosun, C., Kurland, D.B., et al. (2014) Biomarkers as Outcome Predictors in Subarachnoid Hemorrhage—A Systematic Review. Biomarkers, 19, 95-108. https://doi.org/10.3109/1354750X.2014.881418
|
[29]
|
Abboud, T., Mende, K.C., Jung, R., et al. (2017) Prognostic Value of Early S100 Calcium Binding Protein B and Neuron-Specific Enolase in Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage: A Pilot Study. World Neurosurgery, 108, 669-675. https://doi.org/10.1016/j.wneu.2017.09.074
|
[30]
|
Balanca, B., Ritzenthaler, T., Gobert, F., et al. (2020) Significance and Diagnostic Accuracy of Early S100B Serum Concentration after Aneurysmal Subarachnoid Hemorrhage. Journal of Clinical Medicine, 9, Article 1746.
https://doi.org/10.3390/jcm9061746
|
[31]
|
Zhou, Z., Zeng, J., Yu, S., et al. (2022) Neurofilament Light Chain and S100B Serum Levels Are Associated with Disease Severity and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage. Frontiers in Neurology, 13, Article 956043. https://doi.org/10.3389/fneur.2022.956043
|
[32]
|
Troutwine, B.R., Hamid, L., Lysaker, C.R., et al. (2022) Apolipoprotein E and Alzheimer’s Disease. Acta Pharmaceutica Sinica B, 12, 496-510. https://doi.org/10.1016/j.apsb.2021.10.002
|
[33]
|
Suvatha, A., Kandi, S.M., Bhat, D.I., et al. (2017) Apolipoprotein E Polymorphism and the Risk of Aneurysmal Subarachnoid Hemorrhage in a South Indian Population. Cellular & Molecular Biology Letters, 22, Article No. 25.
https://doi.org/10.1186/s11658-017-0059-8
|
[34]
|
Nakatsuka, Y., Shiba, M., Nishikawa, H., et al. (2018) Acute-Phase Plasma Osteopontin as an Independent Predictor for Poor Outcome after Aneurysmal Subarachnoid Hemorrhage. Molecular Neurobiology, 55, 6841-6849.
https://doi.org/10.1007/s12035-018-0893-3
|
[35]
|
Abate, M.G., Moretto, L., Licari, I., et al. (2019) Osteopontin in the Cerebrospinal Fluid of Patients with Severe Aneurysmal Subarachnoid Hemorrhage. Cells, 8, Article 695. https://doi.org/10.3390/cells8070695
|